Related Experiment Video
Updated: Jul 5, 2025

QTL Mapping and CRISPR/Cas9 Editing to Identify a Drug Resistance Gene in Toxoplasma gondii
Published on: June 22, 2017
Integration of expression QTLs with fine mapping via SuSiE
Xiangyu Zhang1, Wei Jiang1, Hongyu Zhao1
1Department of Biostatistics, School of Public Health, Yale University, New Haven, Connecticut, United States of America.
SuSiE2 enhances genetic fine-mapping by integrating expression quantitative trait locus (eQTL) data with the Sum of Single-Effects (SuSiE) model. This approach improves the identification of causal single nucleotide polymorphisms (SNPs) for complex traits.
Area of Science:
- Genetics
- Statistical Genetics
- Bioinformatics
Background:
- Genome-wide association studies (GWASs) identify genetic variants linked to complex traits but struggle with pinpointing causal variants due to linkage disequilibrium (LD).
- Fine-mapping methods aim to assign causality probabilities to candidate variants by considering LD patterns.
- Integrating functional information, such as expression quantitative trait loci (eQTLs), can refine genetic fine-mapping.
Purpose of the Study:
- To introduce SuSiE2, a novel statistical framework that enhances genetic fine-mapping by incorporating eQTL information.
- To improve the accuracy and efficiency of identifying causal variants in GWASs.
- To leverage the Sum of Single-Effects (SuSiE) regression model for integrated eQTL and trait fine-mapping.
Main Methods:
- Developed SuSiE2, a method connecting two SuSiE models: one for eQTL analysis and another for trait fine-mapping.
- Computed posterior inclusion probabilities (PIPs) from an eQTL-based SuSiE model using gene expression levels.
- Utilized these PIPs as prior inclusion probabilities for risk variants in a trait-based SuSiE model.
Main Results:
- SuSiE2 demonstrated improved detection rates of causal single nucleotide polymorphisms (SNPs) compared to standard methods.
- The method reduced the average size of credible sets, enhancing precision in variant localization.
- Evaluations using simulations and real-world data (Alzheimer's disease, BMI) confirmed SuSiE2's superior performance in power, coverage, and precision.
Conclusions:
- SuSiE2 effectively integrates eQTL data into genetic fine-mapping, improving causal variant identification.
- The framework offers enhanced power and precision for fine-mapping complex traits, outperforming existing multi-trait methods.
- SuSiE2 provides a robust approach for dissecting the genetic architecture of complex diseases using GWAS and eQTL data.
More Related Videos
08:27Large-Scale Multi-Omics Genome-Wide Association Studies Mo-GWAS: Guidelines for Sample Preparation and Normalization
Published on: July 27, 2021
11:35Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA
Published on: August 21, 2016